Searched for
SUN PHARMA DRUG PRICE REDUCTION
Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...- Daiichi-Ranbaxy case: Delhi HC orders forensic audit into transactions of Fortis, Singh brothersThe Delhi High Court has appointed a forensic auditor to examine transactions. This audit aims to trace the dissipation of Fortis Healthcar...
- Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations, Cipla contests actionMaharashtra FDA cancelled Cipla's Pune C&F unit drug sale licenses due to serious storage and recall issues. Inspectors found unauthorized ...
- Aurobindo Pharma launches generic Advair Diskus for asthma and COPD in USLannett Company, part of Aurobindo Pharma, has launched generic Advair Diskus in the US, making it the first complex inhalation product fro...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- Notre Dame engineers tested a clear window coating that filters solar heat; model interiors stayed up to 7.2°C cooler without electricityInnovators have developed a cutting-edge transparent coating that effectively blocks solar heat while still allowing natural light to perme...
- 137th Mann Ki Baat: PM Modi highlights history website, backs drug-free youth campaignPrime Minister Narendra Modi discussed a website detailing historical rulers of Bharat. He also highlighted the 'Nasha Mukt Yuva for Viksit...
- Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard'Maharashtra FDA withdrew its order to cancel Cipla Pharma's drug sale license after court intervention. The Bombay High Court criticized th...
- Drugmakers may bear sole responsibility for overpricing essential medicines under NPPA proposalThe National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential med...
- Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...
- Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targetsElara has initiated coverage on four pharmaceutical stocks, assigning Buy, Accumulate and Reduce ratings. Alkem Laboratories emerged as its...
- White House to announce new drug pricing deals with biotechs: ReportThe Trump administration is expected to announce voluntary drug-pricing agreements with midsize biotech companies, requiring discounts for ...
- In a Biosphere 2-linked Arizona study, cherry tomatoes grew beneath solar panels with 50% less irrigation; midday water stress was about 40% lower across cropsUniversity of Arizona researchers studied the effect of solar panel shade on crop growth. Their findings suggest agrivoltaic systems reduce...
- Best gilt mutual funds to invest in August 2026Gilt funds are not recommended to regular debt investors because they are risky and volatile. Gilt funds suffer the most when the rates go ...
- DRL, Emcure get approval to make breakthrough HIV drugIndia's drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for l...
- USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observationsAurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducte...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Indian pharma has little reason to fear TrumpUS tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...
- Nationwide anti-narcotics fortnightly drives to begin from SeptemberAnti-drug agencies will launch a year-long national enforcement drive starting September. This initiative includes apprehending absconding ...
- Sun will require HC nod for Semaglutide tablet launchThe Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisk...
Load More
